Work

Pharmacogenomic modeling of pancreatic cancer (PDAC) for prediction of chemotherapy response and resistance in second-line treatment setting.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.4130

Authors: Kenneth H. Yu, Vineet Sangar, Mark Ricigliano, Manuel Hidalgo, Eileen Mary O'Reilly, Ghassan K. Abou-Alfa, Maeve Aine Lowery, Joseph F. Crotty, Kristen Gary, Brandon Cooper, Rena G. Lapidus, Mariola Sadowska

Institutions: Memorial Sloan Kettering Cancer Center, Institute for Systems Biology, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2605748279

Cites:

Cited by: 1

Related to: 10